Universal Health Services, Inc. (UHS) Competitors & Peers
The 5 largest companies in the same industry as Universal Health Services, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| HCA | Competitor | $494.99 | P/E 16.4RSI 62Cap 103.4 B |
| FSNUF | Peer | $46.86 | P/E 14.3RSI 0Cap 26.4 B |
| FSNUY | Peer | $14.52 | P/E 17.7RSI 78Cap 32.7 B |
| THC | Peer | $283.33 | P/E 8.3RSI 60Cap 22.5 B |
| DVA | Peer | $191.35 | P/E 14.8RSI 56Cap 12.3 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- HCACompetitor
Universal Health Services operates acute care hospitals and behavioral health clinics, competing with HCA Healthcare for patients, physician partnerships, and healthcare personnel in shared markets.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- UEPartner
UHS acts as the primary tenant leasing hospital properties from UE.
Model-inferred, unverified — treat as a lead, not evidence - ACHCCompetitor
Competes directly in providing inpatient behavioral health and psychiatric facilities.
Model-inferred, unverified — treat as a lead, not evidence - IQVPartner
IQVIA provides contract clinical research and trial management services (CRO).
Model-inferred, unverified — treat as a lead, not evidence - AMZNSupplier
Utilizes AWS cloud infrastructure to host genomic sequencing data and clinical trial databases.
Model-inferred, unverified — treat as a lead, not evidence - PFECompetitor
Competes in development and commercialization of therapeutics for similar indications.
Model-inferred, unverified — treat as a lead, not evidence